Lexaria Bioscience Corp. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Accounts Payable and Accrued Liabilities

Accounts Payable and Accrued Liabilities

12 Months Ended

Aug. 31, 2019

Notes to Financial Statements

Accounts Payable and Accrued Liabilities

11.

Accounts Payable and Accrued Liabilities

		August 31				August 31
		2019				2018
		$				$
Accounts Payable
Trades Payable			31,463				14,378
Sales Tax Payable			63,616				1,869
Accrued Liabilities
Trades Payable			41,332				19,538
Balance – Ending			136,411				35,785